FDA Inspection
Sam Van Boxstael, M.D.Sam Van Boxstael, M.D. – FDA Inspection, Jan 19, 2018
Record Details
This FDA Inspection record concerns Sam Van Boxstael, M.D., with an inspection on January 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jenn W. Sellers (Issuing Officer)
- Sherri N. Rohlf (Company Rep)
View Company Profile
ID · 4868c13a-34b1-4c5b-94a4-b31c39e05710
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1039359
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.